Previous close | 0.5540 |
Open | 0.5965 |
Bid | 0.6660 x 0 |
Ask | 0.6775 x 0 |
Day's range | 0.5965 - 0.6605 |
52-week range | 0.4362 - 1.3300 |
Volume | |
Avg. volume | 718 |
Market cap | 119.639M |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significant control over Vaxart by retail investors implies that the general public has more power to...
Explore key financial outcomes, clinical trial updates, and strategic plans from Vaxart's latest earnings call.